Rice Hall James & Associates, LLC Mirum Pharmaceuticals, Inc. Transaction History
Rice Hall James & Associates, LLC
- $1.66 Billion
- Q4 2024
A detailed history of Rice Hall James & Associates, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 238,999 shares of MIRM stock, worth $12.1 Million. This represents 0.6% of its overall portfolio holdings.
Number of Shares
238,999
Previous 242,711
1.53%
Holding current value
$12.1 Million
Previous $9.47 Million
4.41%
% of portfolio
0.6%
Previous 0.56%
Shares
8 transactions
Others Institutions Holding MIRM
# of Institutions
211Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$332 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$231 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$164 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$141 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$132 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.86B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...